Close Menu

As participants in the Avon Walk for Breast Cancer wound their way through Chicago this week, oncologists and cancer researchers met close by at the 2012 annual meeting of the American Society for Clinical Oncology to discuss the latest research in the field. At the meeting's opening session, American Cancer Society CEO John Seffrin said, "We are at an unprecedented place in our understanding" of cancer, and added that cancer death rates are dropping, and doctors must take the opportunity to keep this trend going by teaching their patients everything they know about preventing cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A 50-year-old cold case was cracked using genetic genealogy, the New York Times reports.

NPR reports that some insect pests are now becoming resistant to Bt crops.

Science reports the US Food and Drug Administration did not consult an outside panel in its approval of remdesivir as a COVID-19 treatment.

In Nature this week: a framework for future human genomic research, PORE-cupine approach to study RNA structure using nanopore sequencing, and more.